E Papakonstantinou

ORCID: 0000-0002-9734-5544 · 4 papers in corpus
meta-analysis 2025
Frontiers in reproductive health ·doi:10.3389/frph.2025.1744465

BACKGROUND: Aberrant vascular endothelial growth factor (VEGF)-driven angiogenesis is central to the establishment and persistence of endometriosis. Although numerous anti-angiogenic compounds have been tested, evidence remains fragmented, …

review 2012
Clinical and experimental obstetrics & gynecology

Endometriosis is a multifactorial disease with unclear pathogenesis. Urinary tract endometriosis occurs in about 1% of all endometriotic lesions while isolated ureteral endometriosis is extremely rare. We present a case of intrinsic uretera…

other 2012
Clinical and experimental obstetrics & gynecology

OBJECTIVE: Gonadotrophin-releasing hormone agonist (GnRHa) has been commonly used for the medical treatment of prostate cancer, precocious puberty, endometriosis, adenomyosis and uterine leiomyomas. GnRHa therapy in cases of symptomatic ute…

other 2011
Archives of gynecology and obstetrics ·doi:10.1007/s00404-011-1957-z

INTRODUCTION: Substantial histopathology data provide evidence that endometriosis might be viewed as a precursor lesion of endometrioid and clear cell carcinoma of the ovary, via intermediary atypical borderline lesions. Also, genes involve…